Phathom Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Phathom Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$70.8M, a 98.5% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$288M, a 99.8% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$167M, a 2.97% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$172M, a 27.7% decline from 2021.
  • Phathom Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$135M, a 7.49% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$167M +$5.13M +2.97% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
2022 -$172M -$37.4M -27.7% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
2021 -$135M -$9.42M -7.49% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$126M -$19.5M -18.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$106M -$105M -8571% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$1.23M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.